A feasibility test on a postoperative docetaxel plus TS-1 [S 1] therapy for the patients with stage IIIA or stage IIIB gastric cancer

Trial Profile

A feasibility test on a postoperative docetaxel plus TS-1 [S 1] therapy for the patients with stage IIIA or stage IIIB gastric cancer

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Feb 2017

At a glance

  • Drugs Docetaxel (Primary) ; Gimeracil/oteracil/tegafur (Primary)
  • Indications Gastric cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Jun 2012 Actual end date (Dec 2012) added as reported by University Hospital Medical Information Network - Japan.
    • 26 Jun 2012 Trial phase changed from I to II as reported by University Hospital Medical Information Network - Japan.
    • 26 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top